NCT07743515

Brief Summary

Standard Urotherapy with or without Biofeedback-Based Pelvic Floor Muscle Training for Dysfunctional Voiding in Children

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Mar 2025

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 30, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 4, 2026

Completed
Last Updated

August 4, 2026

Status Verified

July 1, 2026

Enrollment Period

1 year

First QC Date

July 30, 2026

Last Update Submit

July 30, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Achievement of complete response

    Achievement of complete response according to the standard guideline ecommendations

    6 months

Study Arms (2)

Standard Urotherapy

ACTIVE COMPARATOR
Other: Standard Urotherapy

Standard Urotherapy with Biofeedback-Based Pelvic Floor Muscle Training

EXPERIMENTAL
Other: Standard Urotherapy with Biofeedback-Based Pelvic Floor Muscle Training

Interventions

Standard Urotherapy

Standard Urotherapy

Standard Urotherapy with Biofeedback-Based Pelvic Floor Muscle Training

Standard Urotherapy with Biofeedback-Based Pelvic Floor Muscle Training

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Dysfunctional voiding

You may not qualify if:

  • Lower urinary tract trauma (n=1),
  • Urinary tract anomalies
  • Neurological disorders
  • Cognitive impairment
  • Previous treatment for dysfunctional voiding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tanta University

Tanta, Gharbia Governorate, Egypt

Location

Study Officials

  • Mohamed elmaadawy

    Tanta University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 30, 2026

First Posted

August 4, 2026

Study Start

March 1, 2025

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

August 4, 2026

Record last verified: 2026-07

Locations